Sepin-1 non-competitively inhibits separase activity and prevents the growth of leukemia, neuroblastoma, and breast cancer cells in vitro, as well as breast-cancer tumors in vivo in a separase-dependent manner [22]. The gene discussed is ESPL1; the disease is neuroblastoma.